Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2008
08/06/2008EP1951715A2 Aminopyrimidines useful as kinase inhibitors
08/06/2008EP1951714A1 Process for producing 2-(n-butyl)-3-[[2'-(tetrazol-5-yl)biphenyl- 4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
08/06/2008EP1951713A1 Process for the large scale production of rizatriptan benzoate
08/06/2008EP1951712A2 Chemical compounds
08/06/2008EP1951711A1 Indole derivatives as antitumoural compounds
08/06/2008EP1951709A2 Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
08/06/2008EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase
08/06/2008EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase
08/06/2008EP1951690A1 Heterocyclic cetp inhibitors
08/06/2008EP1951679A1 Imidazole compounds that modulate hsp90 activity
08/06/2008EP1951678A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity
08/06/2008EP1951676A2 Lxr modulators
08/06/2008EP1951669A1 Acyl indoles, compositions containing such compounds and methods of use
08/06/2008EP1951667A2 Thrombopoietin activity modulating compounds and methods
08/06/2008EP1907366A4 New imidazole derivatives, preparation method thereof and organic electronic device using the same
08/06/2008EP1773768A4 Pyrrole derivatives as pharmaceutical agents
08/06/2008EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators
08/06/2008EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
08/06/2008EP1474135B9 Indole, azaindole and related heterocyclic pyrrolidine derivatives
08/06/2008EP1409024B1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
08/06/2008EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
08/06/2008EP1385518B1 Benzimidazolone compounds
08/06/2008EP1267819B1 Quinoxaline derivatives, compositions containing them und use as UV-filter
08/06/2008CN101238117A Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments
08/06/2008CN101238106A Fluoro substituted 2-oxo azepan derivatives
08/06/2008CN101238097A Resolution of enantiomeric mixtures of beta-lactams
08/06/2008CN100408573C Pyrazole compounds useful as protein kinase inhibitors
08/06/2008CN100408565C Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
08/06/2008CN100408564C Pyrazole derivatives for treating HIV
08/06/2008CN100408556C Modulation of anxiety through blockade of anandamide hydrolysis
08/06/2008CN100408552C Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production
08/06/2008CN100408099C Oral pharmaceutical composition containing a block copolymer
08/06/2008CN100407922C Antimicrobial additive and ink composition containing said additive
08/05/2008US7408070 Preparing high purity, e.g., 4,4'-oxybis(N-methylphthalimide by contacting a solution of an oxybisphthalimide, a solvent, and an organic phase transfer catalyst with a solid inorganic adsorbent having a cumulative pore volume distribution of at least 20 %; free of residual phase transfer catalyst.
08/05/2008US7407981 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia
08/05/2008US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407968 Compounds
08/05/2008US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
08/05/2008US7407962 Heteroaryl compounds useful as inhibitors or protein kinases
08/05/2008US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma
08/05/2008US7407957 e.g. 4-[5-(piperazine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent; septic shock; ischemic injury; reperfusion injury; hemorrhagic shock; and multiple sclerosis
08/05/2008US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%,
08/05/2008CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
08/05/2008CA2400181C Metal complex type squarylium compounds and optical recording media made by using the same
08/05/2008CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones
07/2008
07/31/2008WO2008090757A1 Squarylium compound, squarylium compound-containing composition, optical filter and front filter for display
07/31/2008WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor
07/31/2008WO2008089636A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
07/31/2008WO2008073687A3 Compounds and compositions as protein kinase inhibitors
07/31/2008WO2008071587A3 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
07/31/2008WO2008071587A2 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
07/31/2008WO2008063232A3 Substituted pyrazolopyrimidines
07/31/2008WO2008062424A3 Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators
07/31/2008WO2008054529A3 Gas generant compositions
07/31/2008WO2008013838A3 Pyridizinone derivatives
07/31/2008WO2008005511A3 Novel inhibitors of hepatitis c virus replication
07/31/2008WO2007077201A9 Piperazine compounds with a herbicidal action
07/31/2008US20080182994 Crystallization from solvent; removal of impurities
07/31/2008US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
07/31/2008US20080182878 benzothienyl containing amido-derivatives, antibacterial agent; quorum sensing regulated virulence factors; inhibiting biofilm formation; virulence gene expression blocking agent, disinfectants, antifouling coatings
07/31/2008US20080182862 e.g. 1-(isoquinolin-1-yl)-N3-(2-(pyrrolidin-1-ylmethyl)benzo[d]oxazol-5-yl)-1H-1,2,4-triazole-3,5-diamine; protein tyrosine kinase receptor Axl inhibitor; bioassay; antiinflammatory, anticarcinogenic agent, anticoagulant; rheumatoid arthritis, vascular disease, diabetic retinopathy, osteoporosis
07/31/2008US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer
07/31/2008US20080182851 Acetylene derivatives as stearoyl coa desaturase inhibitors
07/31/2008US20080182850 3-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4
07/31/2008US20080182847 Anticancer agents; potent Deoxycytidine kinase inhibitors; inhibit thymidine kinase; inhibit uridine kinase; N-[3-(4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)-cyclopentyl]-3-bromo-benzenesulfonamide
07/31/2008US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
07/31/2008US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives
07/31/2008US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides
07/31/2008CA2673164A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
07/31/2008CA2662614A1 Development and characterization of novel proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups
07/30/2008EP1950199A1 Proline derivatives and use thereof as drugs
07/30/2008EP1948649A2 Fungicidal carboxamides
07/30/2008EP1948642A1 4-heteroarymethyl substituted phthalazinone derivatives
07/30/2008EP1948641A1 An improved process for preparation of irbesartan
07/30/2008EP1948639A2 Novel carbocyclic fused cyclic amines
07/30/2008EP1948635A1 Benzimidazole derivatives as gyrase inhibitors
07/30/2008EP1948617A2 Pyrimidinones as casein kinase ii (ck2) modulators
07/30/2008EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
07/30/2008EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto
07/30/2008EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
07/30/2008EP1948597A1 Derivatives for modulation of ion channels
07/30/2008EP1948193A2 Aminopyrimidines useful as kinase inhibitors
07/30/2008EP1948168A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
07/30/2008EP1747204B1 Tri-substituted ureas as cytokine inhibitors
07/30/2008EP1737462B1 Pyrimidines with tie2 (tek) activity
07/30/2008EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
07/30/2008EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
07/30/2008EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors
07/30/2008CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
07/30/2008CN101233115A Indole and benzimidazole derivatives
07/30/2008CN101233112A Benzoquinazoline derivatives and their use in treating bone disorders
07/30/2008CN101230059A Bicycle aza alkyl derivative, preparation method and use in medicine thereof
07/30/2008CN101230058A Bicycle aza alkyl derivative, preparation method and use in medicine thereof
07/30/2008CN101230033A New azabicycloalkane derivatives, preparing method and medicament combination containing the same
07/30/2008CN100406455C Oxazolidinone analog compound containing triazol radical and its preparation method and uses
07/30/2008CN100406454C Pyrazole compounds useful as protein kinase inhibitors.
07/30/2008CN100406453C 4-anilino-quinazoline derivatives as antiproliferative agents
07/30/2008CN100406441C Cyclic amine compounds
07/30/2008CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors